-
1
-
-
33846963814
-
Erythropoietin after a century of research: Younger than ever
-
Jelkmann W. (2007) Erythropoietin after a century of research: younger than ever. Eur. J. Haematol. 78:183-205.
-
(2007)
Eur. J. Haematol.
, vol.78
, pp. 183-205
-
-
Jelkmann, W.1
-
2
-
-
53549097076
-
Erythropoietin-mediated tissue protection: Reducing collateral damage from the primary injury response
-
Brines M, Cerami A. (2008) Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response. J. Intern. Med. 264:405-32.
-
(2008)
J. Intern. Med.
, vol.264
, pp. 405-432
-
-
Brines, M.1
Cerami, A.2
-
3
-
-
0031669157
-
Does erythropoietin administration affect progression of atherosclerosis in Watanabe heritable hyperlipaemic rabbits?
-
Buemi M, et al. (1998) Does erythropoietin administration affect progression of atherosclerosis in Watanabe heritable hyperlipaemic rabbits? Nephrol. Dial. Transplant. 13:2706-8.
-
(1998)
Nephrol. Dial. Transplant.
, vol.13
, pp. 2706-2708
-
-
Buemi, M.1
-
4
-
-
33845790570
-
Longterm erythropoietin therapy decreases CCchemokine levels and intima-media thickness in hemodialyzed patients
-
Pawlak K, Pawlak D, Mysliwiec M. (2006) Longterm erythropoietin therapy decreases CCchemokine levels and intima-media thickness in hemodialyzed patients. Am. J. Nephrol. 26:497-502.
-
(2006)
Am. J. Nephrol.
, vol.26
, pp. 497-502
-
-
Pawlak, K.1
Pawlak, D.2
Mysliwiec, M.3
-
5
-
-
33745917379
-
Long-term treatment with EPO increases serum levels of highdensity lipoprotein in patients with CKD
-
Siamopoulos KC, et al. (2006) Long-term treatment with EPO increases serum levels of highdensity lipoprotein in patients with CKD. Am. J. Kidney Dis. 48:242-9.
-
(2006)
Am. J. Kidney Dis.
, vol.48
, pp. 242-249
-
-
Siamopoulos, K.C.1
-
6
-
-
77951769190
-
Erythropoietin suppresses the formation of macrophage foam cells: Role of liver X receptor alpha
-
Lu KY, et al. (2010) Erythropoietin suppresses the formation of macrophage foam cells: role of liver X receptor alpha. Circulation. 121:1828-37.
-
(2010)
Circulation.
, vol.121
, pp. 1828-1837
-
-
Lu, K.Y.1
-
7
-
-
6944237300
-
Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor
-
Brines M, et al. (2004) Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor. Proc. Natl. Acad. Sci. U. S. A. 101:14907-12.
-
(2004)
Proc. Natl. Acad. Sci. U. S. A.
, vol.101
, pp. 14907-14912
-
-
Brines, M.1
-
8
-
-
29144486069
-
Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study
-
Khorana AA, Francis CW, Culakova E, Lyman GH. (2005) Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study. Cancer. 104:2822-9.
-
(2005)
Cancer.
, vol.104
, pp. 2822-2829
-
-
Khorana, A.A.1
Francis, C.W.2
Culakova, E.3
Lyman, G.H.4
-
9
-
-
34548418912
-
Efficacy and safety of epoetin alfa in critically ill patients
-
Corwin HL, et al. (2007) Efficacy and safety of epoetin alfa in critically ill patients. N. Engl. J. Med. 357:965-76.
-
(2007)
N. Engl. J. Med.
, vol.357
, pp. 965-976
-
-
Corwin, H.L.1
-
10
-
-
42949174250
-
Effect of treatment with epoetin-beta on survival, tumour progression and thromboembolic events in patients with cancer: An updated meta-analysis of 12 randomised controlled studies including 2301 patients
-
Aapro M, Scherhag A, Burger HU. (2008) Effect of treatment with epoetin-beta on survival, tumour progression and thromboembolic events in patients with cancer: an updated meta-analysis of 12 randomised controlled studies including 2301 patients. Br. J. Cancer. 99:14-22.
-
(2008)
Br. J. Cancer.
, vol.99
, pp. 14-22
-
-
Aapro, M.1
Scherhag, A.2
Burger, H.U.3
-
11
-
-
49449099816
-
Nonerythropoietic, tissueprotective peptides derived from the tertiary structure of erythropoietin
-
Brines M, et al. (2008) Nonerythropoietic, tissueprotective peptides derived from the tertiary structure of erythropoietin. Proc. Natl. Acad. Sci. U. S. A. 105:10925-30.
-
(2008)
Proc. Natl. Acad. Sci. U. S. A.
, vol.105
, pp. 10925-10930
-
-
Brines, M.1
-
12
-
-
67650478021
-
Nonerythropoietic tissue protective compounds are highly effective facilitators of wound healing
-
Erbayraktar Z, Erbayraktar S, Yilmaz O, Cerami A, Coleman T, Brines M. (2009) Nonerythropoietic tissue protective compounds are highly effective facilitators of wound healing. Mol. Med. 15:235-41.
-
(2009)
Mol. Med.
, vol.15
, pp. 235-241
-
-
Erbayraktar, Z.1
Erbayraktar, S.2
Yilmaz, O.3
Cerami, A.4
Coleman, T.5
Brines, M.6
-
13
-
-
77956291349
-
Cardioprotection by a nonerythropoietic, tissue-protective peptide mimicking the 3D structure of erythropoietin
-
Ueba H, et al. (2010) Cardioprotection by a nonerythropoietic, tissue-protective peptide mimicking the 3D structure of erythropoietin. Proc. Natl. Acad. Sci. U. S. A. 107:14357-62.
-
(2010)
Proc. Natl. Acad. Sci. U. S. A.
, vol.107
, pp. 14357-14362
-
-
Ueba, H.1
-
14
-
-
79952853429
-
A small nonerythropoietic helix B surface peptide based upon erythropoietin structure is cardioprotective against ischemic myocardial damage
-
Ahmet I, et al. (2011) A small nonerythropoietic helix B surface peptide based upon erythropoietin structure is cardioprotective against ischemic myocardial damage. Mol. Med. 17:194-200.
-
(2011)
Mol. Med.
, vol.17
, pp. 194-200
-
-
Ahmet, I.1
-
15
-
-
0038448027
-
Development of an animal model for spontaneous myocardial infarction (WHHLMI rabbit)
-
Shiomi M, Ito T, Yamada S, Kawashima S, Fan J. (2003) Development of an animal model for spontaneous myocardial infarction (WHHLMI rabbit). Arterioscler. Thromb. Vasc. Biol. 23:1239-44.
-
(2003)
Arterioscler. Thromb. Vasc. Biol.
, vol.23
, pp. 1239-1244
-
-
Shiomi, M.1
Ito, T.2
Yamada, S.3
Kawashima, S.4
Fan, J.5
-
16
-
-
38049093786
-
C-reactive protein induces endothelial cell apoptosis and matrix metalloproteinase-9 production in human mononuclear cells: Implications for the destabilization of atherosclerotic plaque
-
Nabata A, et al. (2008) C-reactive protein induces endothelial cell apoptosis and matrix metalloproteinase-9 production in human mononuclear cells: implications for the destabilization of atherosclerotic plaque. Atherosclerosis. 196:129-35.
-
(2008)
Atherosclerosis.
, vol.196
, pp. 129-135
-
-
Nabata, A.1
-
17
-
-
26244444497
-
Glimepiride induces nitric oxide production in human coronary artery endothelial cells via a PI3-kinase-Akt dependent pathway
-
Ueba H, et al. (2005) Glimepiride induces nitric oxide production in human coronary artery endothelial cells via a PI3-kinase-Akt dependent pathway. Atherosclerosis. 183:35-9.
-
(2005)
Atherosclerosis.
, vol.183
, pp. 35-39
-
-
Ueba, H.1
-
18
-
-
0034978090
-
Fibromuscular cap composition is important for the stability of established atherosclerotic plaques in mature WHHL rabbits treated with statins
-
Shiomi M, Ito T, Hirouchi Y, Enomoto M. (2001) Fibromuscular cap composition is important for the stability of established atherosclerotic plaques in mature WHHL rabbits treated with statins. Atherosclerosis 157:75-84.
-
(2001)
Atherosclerosis
, vol.157
, pp. 75-84
-
-
Shiomi, M.1
Ito, T.2
Hirouchi, Y.3
Enomoto, M.4
-
19
-
-
2142751587
-
Conformational rearrangement in C-reactive protein is required for proinflammatory actions on human endothelial cells
-
Khreiss T, Jozsef L, Potempa LA, Filep JG. (2004) Conformational rearrangement in C-reactive protein is required for proinflammatory actions on human endothelial cells. Circulation. 109:2016-22.
-
(2004)
Circulation.
, vol.109
, pp. 2016-2022
-
-
Khreiss, T.1
Jozsef, L.2
Potempa, L.A.3
Filep, J.G.4
-
21
-
-
33646366683
-
Targeting C-reactive protein for the treatment of cardiovascular disease
-
Pepys MB, et al. (2006) Targeting C-reactive protein for the treatment of cardiovascular disease. Nature. 440:1217-21.
-
(2006)
Nature.
, vol.440
, pp. 1217-1221
-
-
Pepys, M.B.1
-
22
-
-
0037447256
-
Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling
-
Calvillo L, et al. (2003) Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling. Proc. Natl. Acad. Sci. U. S. A. 100:4802-6.
-
(2003)
Proc. Natl. Acad. Sci. U. S. A.
, vol.100
, pp. 4802-4806
-
-
Calvillo, L.1
-
23
-
-
13844320400
-
A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury
-
Fiordaliso F, et al. (2005) A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury. Proc. Natl. Acad. Sci. U. S. A. 102:2046-51.
-
(2005)
Proc. Natl. Acad. Sci. U. S. A.
, vol.102
, pp. 2046-2051
-
-
Fiordaliso, F.1
-
24
-
-
48249136580
-
Antiapoptotic properties of erythropoiesis-stimulating proteins in models of cisplatin-induced acute kidney injury
-
Salahudeen AK, et al. (2008) Antiapoptotic properties of erythropoiesis-stimulating proteins in models of cisplatin-induced acute kidney injury. Am. J. Physiol. Renal Physiol. 294:F1354-65.
-
(2008)
Am. J. Physiol. Renal Physiol.
, vol.294
-
-
Salahudeen, A.K.1
-
25
-
-
0037064261
-
Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis
-
Agnello D, et al. (2002) Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis. Brain Res. 952:128-34.
-
(2002)
Brain Res.
, vol.952
, pp. 128-134
-
-
Agnello, D.1
-
26
-
-
0141784841
-
Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis
-
Villa P, et al. (2003) Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J. Exp. Med. 198:971-5.
-
(2003)
J. Exp. Med.
, vol.198
, pp. 971-975
-
-
Villa, P.1
-
27
-
-
0345356543
-
Endothelial dysfunction in acute and chronic coronary syndromes: Evidence for a pathogenetic role of oxidative stress
-
Valgimigli M, et al. (2003) Endothelial dysfunction in acute and chronic coronary syndromes: evidence for a pathogenetic role of oxidative stress. Arch. Biochem. Biophys. 420:255-61.
-
(2003)
Arch. Biochem. Biophys.
, vol.420
, pp. 255-261
-
-
Valgimigli, M.1
-
29
-
-
33644863344
-
Lesional overexpression of matrix metalloproteinase-9 promotes intraplaque hemorrhage in advanced lesions but not at earlier stages of atherogenesis
-
de Nooijer R, et al. (2006) Lesional overexpression of matrix metalloproteinase-9 promotes intraplaque hemorrhage in advanced lesions but not at earlier stages of atherogenesis. Arterioscler. Thromb. Vasc. Biol. 26:340-6.
-
(2006)
Arterioscler. Thromb. Vasc. Biol.
, vol.26
, pp. 340-346
-
-
de Nooijer, R.1
-
30
-
-
0035957426
-
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
-
Siren AL, et al. (2001) Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc. Natl. Acad. Sci. U. S. A. 98:4044-9.
-
(2001)
Proc. Natl. Acad. Sci. U. S. A.
, vol.98
, pp. 4044-4049
-
-
Siren, A.L.1
-
31
-
-
0034910717
-
Activation of the transcription factor NFkappaB by the erythropoietin receptor: Structural requirements and biological significance
-
Bittorf T, Buchse T, Sasse T, Jaster R, Brock J. (2001) Activation of the transcription factor NFkappaB by the erythropoietin receptor: structural requirements and biological significance. Cell Signal. 13:673-81.
-
(2001)
Cell Signal.
, vol.13
, pp. 673-681
-
-
Bittorf, T.1
Buchse, T.2
Sasse, T.3
Jaster, R.4
Brock, J.5
-
32
-
-
85047691007
-
A novel protective effect of erythropoietin in the infarcted heart
-
Parsa CJ, et al. (2003) A novel protective effect of erythropoietin in the infarcted heart. J. Clin. Invest. 112:999-1007.
-
(2003)
J. Clin. Invest.
, vol.112
, pp. 999-1007
-
-
Parsa, C.J.1
-
33
-
-
0023904446
-
Preventive effect of pravastatin sodium, a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on coronary atherosclerosis and xanthoma in WHHL rabbits
-
Watanabe Y, et al. (1988) Preventive effect of pravastatin sodium, a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on coronary atherosclerosis and xanthoma in WHHL rabbits. Biochim. Biophys. Acta. 960:294-302.
-
(1988)
Biochim. Biophys. Acta.
, vol.960
, pp. 294-302
-
-
Watanabe, Y.1
-
34
-
-
80052761810
-
Macrophage polarization in metabolic disorders: Functions and regulation
-
Chinetti-Gbaguidi G, Staels B. (2011) Macrophage polarization in metabolic disorders: functions and regulation. Curr. Opin. Lipidol. 22:365-72.
-
(2011)
Curr. Opin. Lipidol.
, vol.22
, pp. 365-372
-
-
Chinetti-Gbaguidi, G.1
Staels, B.2
|